1. © 2016 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com Fuel Cell Market size worth $25.5bn by 2024Low Power Wide Area Network Lupus Therapeutics Market size is projected to experience significant growth from 2017 to 2024. Global Market Insights Inc.

2. © 2016 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com  Rising incidence of lupus around the globe and a strong pipeline of various newer therapeutics will drive lupus therapeutics market growth. It is autoimmune disease that arise when the patients’ immune system attacks their own body.  There are several types of known genetic variations related to the disease. Genetics play a significant role in disease development.  Huge significant unmet needs and increase in available therapeutic options for patients with potent clinical benefits will fuel the treatment demand.  Increasing amount of funding and public-private initiatives to generate public awareness will provide significant growth opportunity.  The major restraint for the industry is difficulty in identifying a lupus, since its symptoms mimic several other illnesses. Lack of reimbursement in developing economies may also hinder the lupus therapeutic market growth over the forecast period. Regional Analysis of Infant Nutrition Market:

3. © 2016 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com  Systemic lupus erythematosus market will grow at lucrative rate in the coming years. It affects major tissue or organ in body such as brain, kidneys, heart, or lungs.  Lupus nephritis an inflammation of the kidneys can disturb the body’s capability to filter waste from the blood and may require dialysis or kidney transplant. Discoid (Cutaneous) lupus is limited to skin only and characterized by rashes or sores on skin in various body parts like face, neck, in the mouth, nose, and vagina.  Drug-induced Lupus (DIL) is caused due to prescription of certain drugs. Most commonly linked drugs with DIL are procainamide, prescribed for treatment of uneven heart rhythms; hydralazine, prescribed for treatment for hypertension; and isoniazid, prescribed for treatment for tuberculosis. However, not everyone who take these drugs will develop DIL.

4. © 2016 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com  Various medications are prescribed for the disease management depending on severity and type of the disease.  These medications can range from drug class like non-steroidal anti- inflammatory drugs (NSAIDS), anti-inflammatory drugs, antimalarial drugs, corticosteroids, immunosuppressive drugs anticoagulants and monoclonal antibodies. Ongoing research and recent approvals from FDA will boost the lupus therapeutics market by 2024.  The drugs prescribed for therapeutics can be easily obtained from hospitals, retail pharmacies, ambulatory surgical centers, and online pharmacies. Hospitals, followed by retail pharmacies will account for major industry revenue share. Competitive Market Share of Lupus Therapeutics Market

5. © 2016 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com Browse Full Market Research Report On Lupus Therapeutics Market @ http://bit.ly/2t7Me1vhttp://bit.ly/2t7Me1v Request for an in-depth table of contents for this report @ http://bit.ly/2t2wTmV http://bit.ly/2t2wTmV

6. © 2016 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com Stay In Touch Website: www.gminsights.comwww.gminsights.com Social Media: